Philippe Chamiot-Clerc philippe.chamiot-clerc@sanofi.com & & +33 1 55 71 85 11 | Drug discovery expert, with more than 20 years research experience in academia and pharma industry. Risk manager in charge of Portfolio Risk assessment for develoment projects. In charge of coordination of in vivo plans related to projects (internally and externally). Project, group Head, Core Team member in various therapeutic areas (Neurosciences, diabetes, CV, immuno-inflammation, muscular diseases, opthalmology, pain and urology).with proven records in: Innovative discovery from early stages biology (predictive pharmacological models development) up to entry into clinical development. Successful experience on multiple discovery projects as team leader in a multi-disciplinary and international matrix pharma environment. Interaction as pharmacological expert with the clinical development team to define a development plan (pediatric submission). Involvement as dedicated expert in submission dossier (module 2.4). Management of collaborative projects with industrial or academic partners: partner identification to support business needs, milestones definition, leadership in the planning and coordination of scientific activities in the respect of timelines and budget. Evaluation of external opportunities and participation as expert in strategic working groups (Dry AMD, Dry eye). Laboratory Head in charge of PoC studies, implementation of pre-clinical model, biomarkers identification to support discovery projects. Study director in charge of studies, implementation of pre-clinical model in close relationship with customers, choice of the pharmacological strategy to support pre-clinical development. Co-Management of collaborative and multidisciplinary projects for implementation of electronic labnotebook and IT solution to improve biological results throughput with respect of scientific and ethical constraints. Solid expertise in “Quality in Research”, Best Research Practices and data traceability. Trained as a PhD in cardiovascular pharmacology, with a post-doctoral experience in pulmonary inflammation.

Philippe Chamiot-Clerc

Drug discovery expert, with more than 20 years research experience in academia and pharma industry. Risk manager in...

France

*50 free lookup(s) per month.

No credit card required.

Philippe Chamiot-Clerc’s Emails [email protected]

Philippe Chamiot-Clerc’s Phone Numbers 3315571****

Social Media

Philippe Chamiot-Clerc’s Location France

Philippe Chamiot-Clerc’s Expertise Drug discovery expert, with more than 20 years research experience in academia and pharma industry. Risk manager in charge of Portfolio Risk assessment for develoment projects. In charge of coordination of in vivo plans related to projects (internally and externally). Project, group Head, Core Team member in various therapeutic areas (Neurosciences, diabetes, CV, immuno-inflammation, muscular diseases, opthalmology, pain and urology).with proven records in: Innovative discovery from early stages biology (predictive pharmacological models development) up to entry into clinical development. Successful experience on multiple discovery projects as team leader in a multi-disciplinary and international matrix pharma environment. Interaction as pharmacological expert with the clinical development team to define a development plan (pediatric submission). Involvement as dedicated expert in submission dossier (module 2.4). Management of collaborative projects with industrial or academic partners: partner identification to support business needs, milestones definition, leadership in the planning and coordination of scientific activities in the respect of timelines and budget. Evaluation of external opportunities and participation as expert in strategic working groups (Dry AMD, Dry eye). Laboratory Head in charge of PoC studies, implementation of pre-clinical model, biomarkers identification to support discovery projects. Study director in charge of studies, implementation of pre-clinical model in close relationship with customers, choice of the pharmacological strategy to support pre-clinical development. Co-Management of collaborative and multidisciplinary projects for implementation of electronic labnotebook and IT solution to improve biological results throughput with respect of scientific and ethical constraints. Solid expertise in “Quality in Research”, Best Research Practices and data traceability. Trained as a PhD in cardiovascular pharmacology, with a post-doctoral experience in pulmonary inflammation.

Philippe Chamiot-Clerc’s Current Industry Sanofi

Not the Philippe Chamiot-Clerc you were looking for?

Find accurate emails & phone numbers for over 700M professionals.

Work Experience

Sanofi

Project Risk Manager

Fri Mar 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) — Present

Sanofi

Portfolio Risk Manager

Sun Nov 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Mar 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

Sanofi

Project Head And Group Leader

Sun Oct 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time) — Thu Oct 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Sanofi

Senior Research Scientist

Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Oct 01 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Sanofi

Pain Lab Head

Sun Mar 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time)

Sanofi

Discovery Project Leader

Sun Sep 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Mar 01 2015 00:00:00 GMT+0000 (Coordinated Universal Time)

Sanofi Aventis

Project Team Leader In Drug Discovery And Laboratory Head

Fri Oct 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time) — Sun Sep 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)

Cerep

Study Director

Sat Sep 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) — Fri Oct 01 2004 00:00:00 GMT+0000 (Coordinated Universal Time)

Pelvipharm

Study Director

Thu Feb 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) — Sat Sep 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)

Pfizer

Post Doc

Thu Jul 01 1999 00:00:00 GMT+0000 (Coordinated Universal Time) — Mon Jan 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time)

Inserm

Doctoral Student

Mon Nov 01 1993 00:00:00 GMT+0000 (Coordinated Universal Time) — Tue Dec 01 1998 00:00:00 GMT+0000 (Coordinated Universal Time)

Skills

Languages

FAQ About Philippe Chamiot-Clerc

Philippe Chamiot-Clerc is located at
France

Philippe Chamiot-Clerc is a
Drug discovery expert, with more than 20 years research experience in academia and pharma industry. Risk manager in charge of Portfolio Risk assessment for develoment projects. In charge of coordination of in vivo plans related to projects (internally and externally). Project, group Head, Core Team member in various therapeutic areas (Neurosciences, diabetes, CV, immuno-inflammation, muscular diseases, opthalmology, pain and urology).with proven records in: Innovative discovery from early stages biology (predictive pharmacological models development) up to entry into clinical development. Successful experience on multiple discovery projects as team leader in a multi-disciplinary and international matrix pharma environment. Interaction as pharmacological expert with the clinical development team to define a development plan (pediatric submission). Involvement as dedicated expert in submission dossier (module 2.4). Management of collaborative projects with industrial or academic partners: partner identification to support business needs, milestones definition, leadership in the planning and coordination of scientific activities in the respect of timelines and budget. Evaluation of external opportunities and participation as expert in strategic working groups (Dry AMD, Dry eye). Laboratory Head in charge of PoC studies, implementation of pre-clinical model, biomarkers identification to support discovery projects. Study director in charge of studies, implementation of pre-clinical model in close relationship with customers, choice of the pharmacological strategy to support pre-clinical development. Co-Management of collaborative and multidisciplinary projects for implementation of electronic labnotebook and IT solution to improve biological results throughput with respect of scientific and ethical constraints. Solid expertise in “Quality in Research”, Best Research Practices and data traceability. Trained as a PhD in cardiovascular pharmacology, with a post-doctoral experience in pulmonary inflammation. Sanofi

Philippe Chamiot-Clerc currently works in the
Sanofi

Philippe Chamiot-Clerc specializes in
Drug discovery expert, with more than 20 years research experience in academia and pharma industry. Risk manager in charge of Portfolio Risk assessment for develoment projects. In charge of coordination of in vivo plans related to projects (internally and externally). Project, group Head, Core Team member in various therapeutic areas (Neurosciences, diabetes, CV, immuno-inflammation, muscular diseases, opthalmology, pain and urology).with proven records in: Innovative discovery from early stages biology (predictive pharmacological models development) up to entry into clinical development. Successful experience on multiple discovery projects as team leader in a multi-disciplinary and international matrix pharma environment. Interaction as pharmacological expert with the clinical development team to define a development plan (pediatric submission). Involvement as dedicated expert in submission dossier (module 2.4). Management of collaborative projects with industrial or academic partners: partner identification to support business needs, milestones definition, leadership in the planning and coordination of scientific activities in the respect of timelines and budget. Evaluation of external opportunities and participation as expert in strategic working groups (Dry AMD, Dry eye). Laboratory Head in charge of PoC studies, implementation of pre-clinical model, biomarkers identification to support discovery projects. Study director in charge of studies, implementation of pre-clinical model in close relationship with customers, choice of the pharmacological strategy to support pre-clinical development. Co-Management of collaborative and multidisciplinary projects for implementation of electronic labnotebook and IT solution to improve biological results throughput with respect of scientific and ethical constraints. Solid expertise in “Quality in Research”, Best Research Practices and data traceability. Trained as a PhD in cardiovascular pharmacology, with a post-doctoral experience in pulmonary inflammation.

Philippe Chamiot-Clerc speaks the following languages:
No languages available.

Philippe Chamiot-Clerc has prior experience in the following industries:
Sanofi , Sanofi , Sanofi , Sanofi , Sanofi , Sanofi Aventis , Cerep , Pelvipharm , Pfizer , Inserm

Philippe Chamiot-Clerc has the following professional experience:
Sanofi , Sanofi , Sanofi , Sanofi , Sanofi , Sanofi , Sanofi Aventis , Cerep , Pelvipharm , Pfizer , Inserm .